HIV and methamphetamine (METH) are each associated with deleterious effects on the central nervous system (CNS). Although early evidence suggests that HIV and METH may interact to amplify neural injury via common pathways involving neuroinflammation and vasculopathy, their combined effects on the CNS remain poorly understood. To foster this line of research we propose establishing the Translational Methamphetamine AIDS Research Center (TMARC), which aims to provide scientific leadership, technical support, and opportunities for training to coalesce the efforts of an interdisciplinary group of investigators to elucidate METH/HIV-induced CNS injury. Human projects will examine inhibitory deficits (PI), dysregulated reward processing, interoception, and risk taking (P2), and the effect of HIV co-receptor tropism change on neurocognitive impairment and disease progression (P3). Animal studies will complement and extend the human studies: P4 will explore cognitive and reward effects of METH in a gp120 mouse model, while P5 will explore METH effects on a CCR5 knockout gp120 mouse model with electrophysiological, neuropathological, and neurochemical methods. A third animal project will be nested within PI to enhance translation of the human studies on inhibition to animals. Supporting these Projects will be 4 scientific Cores (Clinical Assessment and Laboratory;Neuropsychiatric;Neuroimaging;Neuroscience and Animal Models) whose activities will be synergized by an Administrative Coordinating Core that includes Units on Data Management and Information Systems, Statistics, and Participant accrual and tracking. These Cores will also serve as incubators for innovative pilot work to facilitate initiation of new studies, and will also serve as a resource by providing access to cohorts, biological samples, and data to inform future studies both by TMARC-affiliated and external investigators. TMARC will also provide opportunities for trainees to develop new research ideas on the CNS effects of HIV and drugs, thereby fostering the next generation of scientists. TMARC's ultimate vision is to become a national resource for translational multidisciplinary research and training in the neuropathogenesis of HIV and substance use.

Public Health Relevance

Powerful antiviral treatments for HIV have reduced mortality, yet neurological complications remain prevalent, perhaps due to drugs of abuse such as METH amplifying HIV's effects. TMARC will provide scientific leadership, technical support, and training for translational research on the combined CNS effects of HIV infection &METH use, which are highly interconnected conditions of major public health importance.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T (11))
Program Officer
Lin, Yu
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
Schools of Medicine
La Jolla
United States
Zip Code
Kamat, Rujvi; Doyle, Katie L; Iudicello, Jennifer E et al. (2016) Neurobehavioral Disturbances During Acute and Early HIV Infection. Cogn Behav Neurol 29:1-10
Noel, Richard J; Kaul, Marcus (2016) The 22nd Scientific Conference of the Society on Neuroimmune Pharmacology. J Neuroimmune Pharmacol 11 Suppl 1:S1-2
Soontornniyomkij, Virawudh; Umlauf, Anya; Soontornniyomkij, Benchawanna et al. (2016) Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. J Neurovirol 22:650-660
Gianella, Sara; Letendre, Scott (2016) Cytomegalovirus and HIV: A Dangerous Pas de Deux. J Infect Dis 214 Suppl 2:S67-74
Kesby, James P; Markou, Athina; Semenova, Svetlana (2016) The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice. Neuropharmacology 109:205-15
Hoenigl, Martin; Little, Susan J (2016) How can we detect HIV during the acute or primary stage of infection? Expert Rev Mol Diagn 16:1049-1051
Bischoff-Grethe, Amanda; Connolly, Colm G; Jordan, Stephan J et al. (2016) Altered reward expectancy in individuals with recent methamphetamine dependence. J Psychopharmacol :
Brown, Gregory G; Jacobus, Joanna; McKenna, Benjamin (2016) Structural imaging for addiction medicine: From neurostructure to neuroplasticity. Prog Brain Res 224:105-27
Hoenigl, Martin; Chaillon, Antoine; Moore, David J et al. (2016) Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr 71:551-7
Pérez-Santiago, Josué; Schrier, Rachel D; de Oliveira, Michelli F et al. (2016) Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection. J Neurovirol 22:191-200

Showing the most recent 10 out of 108 publications